Sonoma Pharmaceuticals Reports Officer and Director Changes
Ticker: SNOA · Form: 8-K · Filed: Oct 23, 2025 · CIK: 1367083
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes
Related Tickers: SONM
TL;DR
Sonoma Pharma (SONM) filed an 8-K for officer/director changes effective Oct 18.
AI Summary
Sonoma Pharmaceuticals, Inc. filed an 8-K on October 23, 2025, reporting changes effective October 18, 2025. The filing covers the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name on June 22, 2006.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: low — This filing primarily reports routine corporate governance changes and does not appear to involve significant financial or operational risks.
Key Players & Entities
- Sonoma Pharmaceuticals, Inc. (company) — Registrant
- Oculus Innovative Sciences, Inc. (company) — Former Company Name
- October 18, 2025 (date) — Effective Date of Changes
- October 23, 2025 (date) — Filing Date
- June 22, 2006 (date) — Date of Name Change
FAQ
What specific officer or director positions were affected by the changes reported in the 8-K?
The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers,' but the specific names and roles are not detailed in the provided excerpt.
Were there any new appointments made to the board or executive team?
Yes, the filing explicitly mentions the 'Election of Directors' and 'Appointment of Certain Officers,' indicating new additions or changes in these roles.
What is the effective date of the reported changes?
The earliest event reported, and thus the effective date of the changes, is October 18, 2025.
When was this 8-K filing submitted to the SEC?
The filing was submitted to the SEC on October 23, 2025.
What was Sonoma Pharmaceuticals, Inc. previously known as?
Sonoma Pharmaceuticals, Inc. was formerly known as Oculus Innovative Sciences, Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on October 23, 2025 regarding Sonoma Pharmaceuticals, Inc. (SNOA).